BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3214386)

  • 1. Suppression of puerperal lactation using jasmine flowers (Jasminum sambac).
    Shrivastav P; George K; Balasubramaniam N; Jasper MP; Thomas M; Kanagasabhapathy AS
    Aust N Z J Obstet Gynaecol; 1988 Feb; 28(1):68-71. PubMed ID: 3214386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jasmine flower extract lowers prolactin.
    Finny P; Stephen C; Jacob R; Tharyan P; Seshadri MS
    Trop Doct; 2015 Apr; 45(2):118-22. PubMed ID: 25505191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
    BMJ; 1991 Jun; 302(6789):1367-71. PubMed ID: 1676318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of puerperal lactation. A double blind study of bromocriptine and placebo.
    Dewhurst CJ; Harrison RF; Biswas S
    Acta Obstet Gynecol Scand; 1977; 56(4):327-31. PubMed ID: 341635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of puerperal lactation by bromocriptine.
    Rolland R; Schellekens LA
    Acta Endocrinol Suppl (Copenh); 1978; 216():119-30. PubMed ID: 347857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of puerperal lactation: evaluation of bromocriptine and placebo.
    Bhardwaj N
    Aust N Z J Obstet Gynaecol; 1979 Aug; 19(3):154-7. PubMed ID: 391210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Puerperal inhibition of lactation with metergoline or bromocriptine].
    Fischer T; Streitmatter A; Gerede A; Frauendorf A; Krause M; Feige A
    Z Geburtshilfe Neonatol; 1995; 199(3):111-5. PubMed ID: 7553254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine in an injectable retard form for puerperal lactation suppression: comparison with Estandron prolongatum.
    Defoort P; Thiery M; Baele G; Clement D; Dhont M
    Obstet Gynecol; 1987 Dec; 70(6):866-9. PubMed ID: 3684122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation.
    Walker S; Groom G; Davis RH; Hibbard BM; Griffiths K
    Lancet; 1975 Nov; 2(7940):842-4. PubMed ID: 53330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and suppression of post-partum lactation with 2-bromo-alpha-ergocryptine (CB-154).
    Macleod SC; Scott J; Lord L; Brodie G; Perlin I; Simpson AA
    Clin Endocrinol (Oxf); 1977; 6 Suppl():65S-70S. PubMed ID: 617072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactation inhibition by a single injection of a new depot-bromocriptine.
    Kremer JA; Rolland R; van der Heijden PF; Schellekens LA; Vosmar MB; Lancranjan I
    Br J Obstet Gynaecol; 1990 Jun; 97(6):527-32. PubMed ID: 2378830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: a comparative study.
    Van Dam LJ; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1981 Nov; 12(5):323-30. PubMed ID: 7333409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of lactation comparing stilboestrol and bromocriptine (CB154).
    Ladipo OA; Ojo OA
    Niger Med J; 1979 Jan; 9(1):77-9. PubMed ID: 463344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum prolactin and the suppression of lactation.
    Weinstein D; Ben-David M; Polishuk WZ
    Br J Obstet Gynaecol; 1976 Sep; 83(9):679-82. PubMed ID: 788774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Rains CP; Bryson HM; Fitton A
    Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dihydroergocryptine on serum prolactin levels and milk secretion in puerperal women.
    Nappi C; Colace G; Di Carlo C; Affinito P; Ruotolo C; Montemagno R; Farace MJ; Mailland F; Di Renzo GF
    Gynecol Endocrinol; 1993 Jun; 7(2):129-33. PubMed ID: 8213227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of lactation. A comparison of bromocriptine and prostaglandin E2.
    England MJ; Tjallinks A; Hofmeyr J; Harber J
    J Reprod Med; 1988 Jul; 33(7):630-2. PubMed ID: 3172062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of four different dosages of injectable bromocriptine retard for puerperal ablactation.
    Duthie SJ; Fuk-Him DL; Fang AH; O'Hoy KM; Pak-Chung H
    Eur J Obstet Gynecol Reprod Biol; 1990 Mar; 34(3):223-8. PubMed ID: 2311809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
    Giorda G; de Vincentiis S; Motta T; Casazza S; Fadin M; D'Alberton A
    Gynecol Obstet Invest; 1991; 31(2):93-6. PubMed ID: 2037265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Puerperal lactation suppression and prolactin.
    De Gezelle H; Dhont M; Thiery M; Parewyck W
    Acta Obstet Gynecol Scand; 1979; 58(5):469-72. PubMed ID: 394563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.